GlassScriptPhysician profile
Lesley L Kenney
NPI 1710963640
$656.11
in general payments reported to CMS, 2019-2025
14 companies · $65.43 in 2025
The $65.43 reported for 2025 was less than what a typical Obstetrics & Gynecology (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
See the full distribution for Obstetrics & Gynecology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $151 · 2022: $116 · 2023: $196 · 2024: $128 · 2025: $65.43.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $389.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $388.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $164.63 | 2021-2024 | |
| Myriad Women'S Health, INC. | $103.74 | 2023 | Myrisk |
| Therapeuticsmd, INC. | $67.68 | 2021 | |
| Organon LLC | $49.97 | 2024 | |
| Merck Sharp & Dohme LLC | $37.96 | 2022-2023 | Gardasil 9 |
| Exeltis, USA INC. | $37.40 | 2025 | Slynd |
| Coopersurgical, INC. | $30.95 | 2024 | Paragard T 380a |
| Abbvie INC. | $28.88 | 2022 | |
| Biogen, INC. | $28.03 | 2025 | Zurzuvae |
| Evofem Biosciences, INC. | $23.81 | 2021 | |
| Hologic Sales and Service, LLC | $22.76 | 2024 | Fluent Fluid Management System, Myosure Tissue Removal Device |
| Bayer Healthcare Pharmaceuticals INC. | $22.64 | 2023 | |
| Astellas Pharma US INC | $22.62 | 2023 | Myrbetriq |
| Shield Therapeutics INC | $15.04 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lesley Kenney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.